Use of Infrared Photomodulation for Hormonal Balance (Joovvin' for Hormonal Health)

ProofPilot60 enrolled

Overview

8-week pilot study looking at the impact of Joovv's infrared photo modulation product on male and female hormone levels.

Study Type

INTERVENTIONAL

Allocation

Purpose

PREVENTION

Masking

NONE

Enrollment

Conditions

Testosterone Deficiency Estrogen Deficiency

Interventions

Joovv Infrared Light DeviceDEVICE

Joovv is the leading manufacturer of personal, in-home red light therapy devices

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * United States resident Exclusion Criteria: * current Joovv or other photomodulation therapy user * under medical supervision for medically treatable illness * significant travel during study period * use of birth control

Locations (1)

ProofPilot (Virtual Study: https://p.proofpilot.com)

New York, New York, United States

Outcomes

Primary Outcomes

Testosterone Change

in males, change from baseline to week 8

Time frame: baseline to week 8

change of thyroid-stimulating hormone (TSH)

in females change in estrogen and progesterone from baseline to week 8

Time frame: baseline to week 8

Self report general wellness

series of questions at baseline and week 8 on general wellness (modified Short Form-36)

Time frame: baseline to week 8

Central Contacts

Matthew M Amsden

CONTACT

3232844626 crew@proofpilot.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.